A detailed history of Tekla Capital Management LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 567,147 shares of CRBU stock, worth $930,121. This represents 0.1% of its overall portfolio holdings.

Number of Shares
567,147
Previous 567,147 -0.0%
Holding current value
$930,121
Previous $3.01 Million 19.96%
% of portfolio
0.1%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$5.34 - $12.79 $706,108 - $1.69 Million
-132,230 Reduced 18.91%
567,147 $5.98 Million
Q3 2021

Nov 12, 2021

BUY
$15.75 - $30.29 $11 Million - $21.2 Million
699,377 New
699,377 $15.6 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $99.8M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.